Lista de obras - Giuseppe V Masucci - Dominio Público Uruguay

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): late breaking abstracts: National Harbor, MD, USA. 9-13 November 2016.

artículo científico publicado en 2016

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

artículo científico publicado en 2016

A better immune reaction to Erbb-2 tumors is elicited in mice by DNA vaccines encoding rat/human chimeric proteins

artículo científico publicado en 2010

A novel approach for HLA-A typing in formalin-fixed paraffin-embedded-derived DNA.

artículo científico

A phase I clinical trial combining dendritic cell vaccination with adoptive T cell transfer in patients with stage IV melanoma.

artículo científico publicado en 2014

A phase I trial of DNA vaccination with a plasmid expressing prostate-specific antigen in patients with hormone-refractory prostate cancer.

artículo científico publicado en 2004

A short-term dietary supplementation of high doses of vitamin E increases T helper 1 cytokine production in patients with advanced colorectal cancer

artículo científico publicado en 2002

A short-term dietary supplementation with high doses of vitamin E increases NK cell cytolytic activity in advanced colorectal cancer patients.

artículo científico publicado en 2006

A systematic approach to biomarker discovery; preamble to "the iSBTc-FDA taskforce on immunotherapy biomarkers".

artículo científico publicado en 2008

Active immunosurveillance in the tumor microenvironment of colorectal cancer is associated with low frequency tumor budding and improved outcome

artículo científico publicado en 2015

Alternating chemo-immunotherapy with temozolomide and low-dose interleukin-2 in patients with metastatic melanoma.

artículo científico publicado en 2006

Analysis of HLA class I-II haplotype frequency and segregation in a cohort of patients with advanced stage ovarian cancer

artículo científico publicado en 2007

Cancer classification using the Immunoscore: a worldwide task force

artículo científico publicado en 2012

Clinical Performance of the Consensus Immunoscore in Colon Cancer in the Asian Population from the Multicenter International SITC Study

artículo científico publicado en 2022

Complete and long-lasting clinical responses in immune checkpoint inhibitor-resistant, metastasized melanoma treated with adoptive T cell transfer combined with DC vaccination

artículo científico publicado en 2020

Correlation between HLA-A2 gene frequency, latitude, ovarian and prostate cancer mortality rates.

artículo científico publicado en 2004

Correlation of HLA-A02* genotype and HLA class I antigen down-regulation with the prognosis of epithelial ovarian cancer

artículo científico publicado en 2012

Defining the critical hurdles in cancer immunotherapy

artículo científico publicado en 2011

Dendritic cells highly quoted on immunotherapy stock market

artículo científico publicado en 2002

Development of a technology platform for large-scale clinical grade production of DC.

artículo científico publicado en 2004

Effects of human plasma proteins on maturation of monocyte-derived dendritic cells.

artículo científico publicado en 2005

Efficient Harvest of In Vivo IL-2-Activated CD3+ Lymphocytes for Adoptive Immunotherapy by Selective Leukapheresis (Lymphocytapheresis) ⬇️

artículo científico publicado el 1 de junio de 1997

Emerging concepts in biomarker discovery; the US-Japan Workshop on Immunological Molecular Markers in Oncology

artículo científico publicado en 2009

Frequent loss of HLA-A2 expression in metastasizing ovarian carcinomas associated with genomic haplotype loss and HLA-A2-restricted HER-2/neu-specific immunity.

artículo científico publicado en 2006

Future perspectives in melanoma research : Meeting report from the "Melanoma Bridge". Napoli, December 1st-4th 2015.

artículo científico publicado en 2016

Future perspectives in melanoma research: meeting report from the "Melanoma Bridge", Napoli, December 5th-8th 2013.

artículo científico publicado en 2014

Future perspectives in melanoma research: meeting report from the "Melanoma Bridge": Napoli, December 3rd-6th 2014.

artículo científico publicado en 2015

GM-CSF at relatively high topic concentrations can significantly enhance the healing of surgically induced chronic wounds after radiotherapy

artículo científico publicado en 2001

Genotyping of human leukocyte antigen (HLA) ancestral haplotypes as prognostic marker in cancer using PCR analysis.

artículo científico publicado en 2014

HLA class I and II expression in oropharyngeal squamous cell carcinoma in relation to tumor HPV status and clinical outcome

artículo científico publicado en 2013

HLA-A*02 in relation to outcome in human papillomavirus positive tonsillar and base of tongue cancer

artículo científico publicado en 2014

HLA-dependent tumour development: a role for tumour associate macrophages?

artículo científico publicado en 2013

Human leucocyte antigen (HLA) A2 as a negative clinical prognostic factor in patients with advanced ovarian cancer.

artículo científico publicado en 2006

Hydrogen peroxide secreted by tumor-derived macrophages down-modulates signal-transducing zeta molecules and inhibits tumor-specific T cell-and natural killer cell-mediated cytotoxicity

scientific article published on 01 June 1996

Immature immunosuppressive CD14+HLA-DR-/low cells in melanoma patients are Stat3hi and overexpress CD80, CD83, and DC-sign

artículo científico publicado en 2010

Inhibition of activated/memory (CD45RO(+)) T cells by oxidative stress associated with block of NF-kappaB activation

artículo científico publicado en 2001

International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study

artículo científico publicado en 2018

Ipilimumab treatment results in an early decrease in the frequency of circulating granulocytic myeloid-derived suppressor cells as well as their Arginase1 production.

artículo científico publicado en 2013

Leakage around voice prosthesis in laryngectomees: treatment with local GM-CSF

artículo científico publicado en 2001

Melanoma and immunotherapy bridge 2015 : Naples, Italy. 1-5 December 2015

artículo científico publicado en 2016

Multicenter International Society for Immunotherapy of Cancer Study of the Consensus Immunoscore for the Prediction of Survival and Response to Chemotherapy in Stage III Colon Cancer

artículo científico publicado en 2020

Myeloid-derived suppressor cells and their role in CTLA-4 blockade therapy

artículo científico publicado en 2014

Myeloid-derived suppressor cells impair the quality of dendritic cell vaccines.

artículo científico publicado en 2011

New clinical applications of granulocyte-macrophage colony-stimulating factor.

artículo científico publicado en 1996

Non-classical HLA-class I expression in serous ovarian carcinoma: Correlation with the HLA-genotype, tumor infiltrating immune cells and prognosis

artículo científico publicado en 2015

PD-1 checkpoint blockade in advanced melanoma patients: NK cells, monocytic subsets and host PD-L1 expression as predictive biomarker candidates

scientific article published on 28 August 2020

PD-L1 expression as a potential predictive biomarker

artículo científico publicado en 2015

Perspectives in melanoma: Meeting report from the Melanoma Bridge (30 November-2 December, 2017, Naples, Italy)

artículo científico publicado en 2018

Perspectives in melanoma: meeting report from the Melanoma Bridge (November 29th-1 December 1st, 2018, Naples, Italy)

artículo científico publicado en 2019

Planning a Bayesian early-phase phase I/II study for human vaccines in HER2 carcinomas

artículo científico publicado en 2010

Prognostic Interactions between FAP+ Fibroblasts and CD8a+ T Cells in Colon Cancer

artículo científico publicado en 2020

Prognostic significance of tumor iNOS and COX-2 in stage III malignant cutaneous melanoma.

artículo científico publicado en 2008

Protein profiling of fine-needle aspirates reveals subtype-associated immune signatures and involvement of chemokines in breast cancer

artículo científico publicado en 2019

Recommendations from the iSBTc-SITC/FDA/NCI Workshop on Immunotherapy Biomarkers

artículo científico publicado en 2011

Stereotactic Ablative Radio Therapy (SABR) followed by immunotherapy a challenge for individualized treatment of metastatic solid tumours

artículo científico publicado en 2012

Synthetic peptides derived from the melanocyte-stimulating hormone receptor MC1R can stimulate HLA-A2-restricted cytotoxic T lymphocytes that recognize naturally processed peptides on human melanoma cells

artículo científico publicado en 1997

The common Scandinavian human leucocyte antigen ancestral haplotype 62.1 as prognostic factor in patients with advanced malignant melanoma

artículo científico publicado en 2009

The need for a network to establish and validate predictive biomarkers in cancer immunotherapy

artículo científico publicado en 2017

Therapeutic efficacy by recombinant human granulocyte/monocyte-colony stimulating factor on mucositis occurring in patients with oral and oropharynx tumors treated with curative radiotherapy: a multicenter open randomized phase III study

scientific article published on 01 January 2005

Towards the introduction of the 'Immunoscore' in the classification of malignant tumours

artículo científico publicado en 2014

Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1

scientific article published on 01 January 1999

Validation of the Immunoscore (IM) as a prognostic marker in stage I/II/III colon cancer: Results of a worldwide consortium-based analysis of 1,336 patients

Will modern cancer vaccines reach clinical practice?

artículo científico publicado en 1999

World-Wide Immunoscore Task Force: meeting report from the "Melanoma Bridge", Napoli, November 30th-December 3rd, 2016

artículo científico publicado en 2017

[Paradigmatic shift in oncology: individualized melanoma treatment].

artículo científico publicado en 2011

Lista de obras de Giuseppe V Masucci

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): late breaking abstracts: National Harbor, MD, USA. 9-13 November 2016.

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

A better immune reaction to Erbb-2 tumors is elicited in mice by DNA vaccines encoding rat/human chimeric proteins

A novel approach for HLA-A typing in formalin-fixed paraffin-embedded-derived DNA.

A phase I clinical trial combining dendritic cell vaccination with adoptive T cell transfer in patients with stage IV melanoma.

A phase I trial of DNA vaccination with a plasmid expressing prostate-specific antigen in patients with hormone-refractory prostate cancer.

A short-term dietary supplementation of high doses of vitamin E increases T helper 1 cytokine production in patients with advanced colorectal cancer

A short-term dietary supplementation with high doses of vitamin E increases NK cell cytolytic activity in advanced colorectal cancer patients.

A systematic approach to biomarker discovery; preamble to "the iSBTc-FDA taskforce on immunotherapy biomarkers".

Active immunosurveillance in the tumor microenvironment of colorectal cancer is associated with low frequency tumor budding and improved outcome

Alternating chemo-immunotherapy with temozolomide and low-dose interleukin-2 in patients with metastatic melanoma.

Analysis of HLA class I-II haplotype frequency and segregation in a cohort of patients with advanced stage ovarian cancer

Cancer classification using the Immunoscore: a worldwide task force

Clinical Performance of the Consensus Immunoscore in Colon Cancer in the Asian Population from the Multicenter International SITC Study

Complete and long-lasting clinical responses in immune checkpoint inhibitor-resistant, metastasized melanoma treated with adoptive T cell transfer combined with DC vaccination

Correlation between HLA-A2 gene frequency, latitude, ovarian and prostate cancer mortality rates.

Correlation of HLA-A02* genotype and HLA class I antigen down-regulation with the prognosis of epithelial ovarian cancer

Defining the critical hurdles in cancer immunotherapy

Dendritic cells highly quoted on immunotherapy stock market

Development of a technology platform for large-scale clinical grade production of DC.

Effects of human plasma proteins on maturation of monocyte-derived dendritic cells.

Efficient Harvest of In Vivo IL-2-Activated CD3+ Lymphocytes for Adoptive Immunotherapy by Selective Leukapheresis (Lymphocytapheresis) ⬇️

Emerging concepts in biomarker discovery; the US-Japan Workshop on Immunological Molecular Markers in Oncology

Frequent loss of HLA-A2 expression in metastasizing ovarian carcinomas associated with genomic haplotype loss and HLA-A2-restricted HER-2/neu-specific immunity.

Future perspectives in melanoma research : Meeting report from the "Melanoma Bridge". Napoli, December 1st-4th 2015.

Future perspectives in melanoma research: meeting report from the "Melanoma Bridge", Napoli, December 5th-8th 2013.

Future perspectives in melanoma research: meeting report from the "Melanoma Bridge": Napoli, December 3rd-6th 2014.

GM-CSF at relatively high topic concentrations can significantly enhance the healing of surgically induced chronic wounds after radiotherapy

Genotyping of human leukocyte antigen (HLA) ancestral haplotypes as prognostic marker in cancer using PCR analysis.

HLA class I and II expression in oropharyngeal squamous cell carcinoma in relation to tumor HPV status and clinical outcome

HLA-A*02 in relation to outcome in human papillomavirus positive tonsillar and base of tongue cancer

HLA-dependent tumour development: a role for tumour associate macrophages?

Human leucocyte antigen (HLA) A2 as a negative clinical prognostic factor in patients with advanced ovarian cancer.

Hydrogen peroxide secreted by tumor-derived macrophages down-modulates signal-transducing zeta molecules and inhibits tumor-specific T cell-and natural killer cell-mediated cytotoxicity

Immature immunosuppressive CD14+HLA-DR-/low cells in melanoma patients are Stat3hi and overexpress CD80, CD83, and DC-sign

Inhibition of activated/memory (CD45RO(+)) T cells by oxidative stress associated with block of NF-kappaB activation

International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study

Ipilimumab treatment results in an early decrease in the frequency of circulating granulocytic myeloid-derived suppressor cells as well as their Arginase1 production.

Leakage around voice prosthesis in laryngectomees: treatment with local GM-CSF

Melanoma and immunotherapy bridge 2015 : Naples, Italy. 1-5 December 2015

Multicenter International Society for Immunotherapy of Cancer Study of the Consensus Immunoscore for the Prediction of Survival and Response to Chemotherapy in Stage III Colon Cancer

Myeloid-derived suppressor cells and their role in CTLA-4 blockade therapy

Myeloid-derived suppressor cells impair the quality of dendritic cell vaccines.

New clinical applications of granulocyte-macrophage colony-stimulating factor.

Non-classical HLA-class I expression in serous ovarian carcinoma: Correlation with the HLA-genotype, tumor infiltrating immune cells and prognosis

PD-1 checkpoint blockade in advanced melanoma patients: NK cells, monocytic subsets and host PD-L1 expression as predictive biomarker candidates

PD-L1 expression as a potential predictive biomarker

Perspectives in melanoma: Meeting report from the Melanoma Bridge (30 November-2 December, 2017, Naples, Italy)

Perspectives in melanoma: meeting report from the Melanoma Bridge (November 29th-1 December 1st, 2018, Naples, Italy)

Planning a Bayesian early-phase phase I/II study for human vaccines in HER2 carcinomas

Prognostic Interactions between FAP+ Fibroblasts and CD8a+ T Cells in Colon Cancer

Prognostic significance of tumor iNOS and COX-2 in stage III malignant cutaneous melanoma.

Protein profiling of fine-needle aspirates reveals subtype-associated immune signatures and involvement of chemokines in breast cancer

Recommendations from the iSBTc-SITC/FDA/NCI Workshop on Immunotherapy Biomarkers

Stereotactic Ablative Radio Therapy (SABR) followed by immunotherapy a challenge for individualized treatment of metastatic solid tumours

Synthetic peptides derived from the melanocyte-stimulating hormone receptor MC1R can stimulate HLA-A2-restricted cytotoxic T lymphocytes that recognize naturally processed peptides on human melanoma cells

The common Scandinavian human leucocyte antigen ancestral haplotype 62.1 as prognostic factor in patients with advanced malignant melanoma

The need for a network to establish and validate predictive biomarkers in cancer immunotherapy

Therapeutic efficacy by recombinant human granulocyte/monocyte-colony stimulating factor on mucositis occurring in patients with oral and oropharynx tumors treated with curative radiotherapy: a multicenter open randomized phase III study

Towards the introduction of the 'Immunoscore' in the classification of malignant tumours

Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1

Validation of the Immunoscore (IM) as a prognostic marker in stage I/II/III colon cancer: Results of a worldwide consortium-based analysis of 1,336 patients

Will modern cancer vaccines reach clinical practice?

World-Wide Immunoscore Task Force: meeting report from the "Melanoma Bridge", Napoli, November 30th-December 3rd, 2016

[Paradigmatic shift in oncology: individualized melanoma treatment].